ClinicalTrials.gg
RecruitingNCT07861282TEPULUpdated Oct 21, 2026

Telerehabilitation Exercise Program for Postoperative Recovery in Lung Cancer.

An interventional study of Therapeutic Exercise-Based Telerehabilitation and Usual Postoperative Care in Lung Neoplasms and Thoracic Surgery Lung, sponsored by University of Seville. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by University of Seville · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 21, 2026Now RecruitingSite recruiting status changed+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 240 studies in Lung Neoplasms with a site in Spain — 65 open to participants now, 102 under way, 27 of them phase 3. Lung Neoplasms · Spain.

Planned enrollment
166th of 201
56 · median 222
Started
2026
with 12 others
No phase
20 of 240
7 open now
Primary completion
2028-04
later than 61 of 101 live
Registered
240th of 240
by date

Among the 240 studies in Lung Neoplasms with a site in Spain, this one is the 166th largest by planned enrollment of the 201 interventional ones that give a count, is one of 13 that started in 2026, is one of 20 with no phase, reaches primary completion later than 61 of the 101 other live ones, and was the 240th registered.

Lung Neoplasms

5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.

Browse Lung Neoplasms studies →

Open to participants now

65 of the 240 studies in Lung Neoplasms with a site in Spain are open now. Recruiting first, the newest first:

59 more — sign in →

All 65 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 240 studies in Lung Neoplasms with a site in Spain, or all of them as a file.
02

Study summary

Lung cancer is one of the leading causes of cancer-related morbidity and mortality worldwide. Thoracic surgery remains the treatment of choice for patients with early-stage disease; however, postoperative recovery is frequently associated with reduced functional capacity, decreased physical activity levels, pulmonary complications, dyspnea, and impaired quality of life. Early physiotherapy interventions are recommended to minimize these adverse outcomes, although access to postoperative rehabilitation services remains limited in many healthcare settings, including the Andalusian Public Health System.

Telerehabilitation has emerged as a promising strategy to improve access to rehabilitation services by delivering therapeutic exercise and clinical follow-up remotely. Previous studies have demonstrated that telerehabilitation is safe, effective, and cost-efficient across different clinical populations. However, evidence regarding its effectiveness in patients recovering from lung cancer surgery remains limited.

This single-blind randomized controlled trial aims to compare the effects of an eight-week telerehabilitation program based on therapeutic exercise with usual postoperative care in patients with lung cancer undergoing thoracic surgery. Participants allocated to the intervention group will receive 24 therapeutic exercise sessions and 8 online clinical follow-up sessions delivered through the Rehbody platform over an 8-week period. Outcomes will include functional capacity, dyspnea, physical activity level, postoperative pulmonary complications, and health-related quality of life.

The study is designed to address the following research question: In adults with lung cancer undergoing thoracic surgery (Population), does an eight-week therapeutic exercise-based telerehabilitation program (Intervention), compared with usual postoperative care (Comparison), improve postoperative recovery as measured by functional capacity, dyspnea, physical activity level, postoperative pulmonary complications, and quality of life (Outcomes)?

Read the detailed description

Lung cancer remains the leading cause of cancer-related mortality worldwide and continues to impose a substantial burden on healthcare systems. Surgical resection is considered the standard treatment for patients with resectable disease and offers the best opportunity for long-term survival. However, despite advances in surgical techniques and perioperative care, recovery following thoracic surgery is frequently characterized by impaired physical function, reduced exercise capacity, dyspnea, decreased physical activity levels, postoperative pulmonary complications, and deterioration in health-related quality of life.

The physical and functional consequences of lung cancer treatment may persist for months or years after surgery and can negatively affect independence, participation in daily activities, and overall well-being. Postoperative rehabilitation and therapeutic exercise have therefore become important components of comprehensive cancer care. Early physiotherapy interventions aim to prevent postoperative pulmonary complications, facilitate recovery of physical function, reduce symptom burden, and promote a safe return to daily activities. Previous studies have shown that exercise-based rehabilitation following lung resection can improve functional capacity and quality of life while reducing postoperative morbidity.

Despite these recognized benefits, access to structured rehabilitation programs remains limited in many healthcare settings due to geographical, logistical, organizational, and resource-related barriers. This challenge is particularly relevant in publicly funded healthcare systems, where rehabilitation services may not be universally available after hospital discharge. As a result, many patients do not receive adequate follow-up rehabilitation during a critical phase of postoperative recovery.

Telerehabilitation has emerged as a promising alternative model of healthcare delivery that enables rehabilitation services to be provided remotely through digital technologies. This approach has the potential to improve accessibility, continuity of care, adherence to prescribed exercise programs, and patient engagement while reducing travel requirements and healthcare costs. Growing evidence supports the safety, feasibility, and effectiveness of telemedicine and telerehabilitation interventions across a variety of chronic and oncological conditions.

In patients with lung cancer, recent studies have reported encouraging results regarding the use of mobile applications and remotely supervised rehabilitation programs. These interventions have been associated with improved adherence to treatment, enhanced functional recovery, better pulmonary function, increased physical activity levels, reduced symptom burden, and improvements in quality of life. Furthermore, digital rehabilitation strategies may facilitate long-term monitoring and support during the postoperative period, helping patients maintain active participation in their recovery process.

Nevertheless, important knowledge gaps remain. The number of high-quality randomized controlled trials specifically evaluating structured postoperative telerehabilitation programs after lung cancer surgery is still limited. Existing studies have often included small sample sizes, heterogeneous interventions, or mixed cancer populations, making it difficult to establish definitive recommendations regarding the optimal design and clinical effectiveness of telerehabilitation in this population. Additional research is needed to determine whether remotely delivered therapeutic exercise programs can produce clinically meaningful improvements in postoperative recovery and patient-centered outcomes.

The present randomized controlled trial has been designed to address this evidence gap by evaluating the effectiveness of an eight-week telerehabilitation program based on therapeutic exercise in patients undergoing thoracic surgery for lung cancer. Participants allocated to the intervention group will receive a structured and progressive exercise program delivered through a dedicated telerehabilitation platform, combined with regular online clinical follow-up sessions. The intervention incorporates aerobic exercise, muscle strengthening exercises, respiratory muscle training, individualized progression, and continuous monitoring of adherence and symptoms. Participants assigned to the control group will receive the usual postoperative physiotherapy care routinely provided after thoracic surgery.

The study will evaluate the impact of the intervention on key dimensions of postoperative recovery, including functional capacity, dyspnea, physical activity levels, postoperative pulmonary complications, and health-related quality of life. Assessments will be performed before surgery, after completion of the intervention period, and following a short-term follow-up period to explore the maintenance of potential benefits.

The findings of this study may contribute to the development of evidence-based rehabilitation pathways for patients recovering from lung cancer surgery. If effective, this telerehabilitation model could represent an accessible, scalable, and cost-efficient strategy for improving postoperative outcomes and expanding access to rehabilitation services within routine clinical practice.

03

Conditions studied

  • Lung Neoplasms
  • Thoracic Surgery Lung

Keywords

  • Thoracic Surgery
  • Lung Neoplasms
  • Telerehabilitation
  • Dyspnea
  • Exercise Therapy
  • Quality of Life
  • Postoperative Complications
04

Who can participate

The criteria were revised on the registry on Oct 21, 2026. See what changed

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 80 years.
  • confirmed primary lung cancer (stage 0 to IIIB).
  • Patients who have undergone thoracic surgery for lung cancer.
  • Medical clearance to participate in an exercise-based rehabilitation program.
  • Ability to understand and communicate verbally.
  • Access to a smartphone and/or computer with internet connection.

Exclusion criteria

Exclusion Criteria:

  • Any medical condition or comorbidity that contraindicates participation in an exercise program.
  • Current psychiatric disorder that may interfere with study participation.
  • Inability to provide written .
  • Previous thoracic surgery.
  • History of another within the past one year.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Histologically or cytologically confirmed

The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).

Your pathology report is the document that shows this.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Active comparator
    Telerehabilitation + Usual Care

    Behavioral: Therapeutic Exercise-Based Telerehabilitation

  • Active comparator
    Usual Care

    Other: Usual Postoperative Care

Interventions

  • BehavioralTherapeutic Exercise-Based Telerehabilitation

    Participants will receive an 8-week telerehabilitation program delivered through the RehBody platform. The intervention includes 24 supervised therapeutic exercise sessions and 8 online clinical follow-up sessions. Exercise sessions incorporate aerobic training, strength exercises, respiratory muscle training, individualized progression, symptom monitoring, and adherence support. Participants will also receive usual postoperative care.

  • OtherUsual Postoperative Care

    Participants assigned to the control group will receive usual postoperative care routinely provided after thoracic surgery for lung cancer. This includes early mobilization, progressive ambulation according to individual tolerance, deep breathing exercises, active upper-limb and trunk mobility exercises, cough training with wound protection, and discharge recommendations for home-based recovery. No structured telerehabilitation or supervised exercise program will be provided after hospital discharge.

06

What researchers measure

Primary outcomes

  1. Functional capacity measured by the One-Minute Sit-to-Stand Test (1MSTS)

    Functional capacity will be assessed using the One-Minute Sit-to-Stand Test (1MSTS). Participants will stand up and sit down from a standardized chair as many times as possible within one minute. The total number of completed repetitions will be recorded. There is no fixed maximum value, and higher numbers of repetitions indicate better functional capacity.

    Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).

Secondary outcomes

  1. Dyspnea measured by the Modified Medical Research Council (mMRC) Dyspnea Scale.

    Dyspnea will be assessed using the Modified Medical Research Council (mMRC) Dyspnea Scale, a 5-point ordinal scale. Scores range from 0 to 4 (minimum 0, maximum 4). Higher scores indicate greater breathlessness and functional limitation due to dyspnea (worse outcome).

    Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).

  2. Physical activity level measured by the International Physical Activity Questionnaire - Short Form (IPAQ-SF), MET-minutes/week.

    Physical activity will be assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF). Results will be expressed as total MET-minutes/week (metabolic equivalent of task-minutes per week), with a minimum of 0 and no fixed maximum. Higher values indicate a higher level of physical activity (better outcome). Participants will also be categorized as having low, moderate, or high physical activity levels according to the standardized IPAQ scoring protocol.

    Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).

  3. Incidence of postoperative pulmonary complications defined by the European Perioperative Clinical Outcome (EPCO) criteria.

    Postoperative pulmonary complications will be collected from clinical records and defined according to the European Perioperative Clinical Outcome (EPCO) criteria. Complications will be recorded from hospital discharge until the end of the intervention and follow-up period. The outcome will be reported as the number and percentage of participants with at least one postoperative pulmonary complication.

    Time frame: From hospital discharge to 12-week follow-up.

  4. Health-related quality of life measured by the EQ-5D-5L descriptive system (index value).

    Health-related quality of life will be assessed using the descriptive system of the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), which covers five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) with five levels each. Responses will be converted into an index value using a country-specific value set. A value of 1 represents full health and 0 represents a state equivalent to dead; negative values indicate states considered worse than dead, and the minimum depends on the value set used. Higher values indicate better health status (better outcome).

    Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).

  5. Self-rated health measured by the EuroQol Visual Analogue Scale (EQ-VAS).

    Self-rated health will be assessed using the EuroQol Visual Analogue Scale (EQ-VAS), on which participants rate their health on the day of assessment. Scores range from 0 (the worst health you can imagine) to 100 (the best health you can imagine). Higher scores indicate better perceived health status (better outcome).

    Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).

07

Study locations

1 of 1 sites recruiting
  • Hospital Universitario Virgen Macarena
    Seville, Andalusia 41009, Spain
    Recruiting
    • David Ortega Valle, PT, MSc · Contactdavortval@alum.us.es · 663616650
    • María Jesús Casuso Holgado, PT, PhD · Principal investigator
    • David Ortega Valle, PT, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Apr 2028, 19 months after the start.

Of 871 non-industry interventional studies with no phase under Lung Neoplasms, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's planned 19 months is below that.

Counting every sponsor, half of 922 studies reached it within 34 months; a quarter within 15 and three quarters within 67.

Start moved once since we started tracking on Sep 25, 2026: Oct 2026 → Sep 2026, on Oct 21, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2026
First posted
Oct 6, 2026
StartActual
Sep 8, 2026was Oct 2026
Primary completionEst.
Apr 2028
CompletionEst.
Nov 2028
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 21, 2026
Sites
Hospital Universitario Virgen Macarena is now Recruiting
Oct 21, 2026
Start date
Oct 2026→Sep 8, 2026 (actual)
Oct 21, 2026
Eligibility
1 exclusion criterion edited
What changed in the criteria
Exclusion criteria
  • EditedHistory of another malignancy within the past five yearsone year.
Oct 21, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Functional CapacityNow Functional capacity measured by the One-Minute Sit-to-Stand Test (1MSTS)Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up) → Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
Oct 21, 2026
Secondary outcomes
5 added, 4 removed
What changed in the outcomes
  • AddedDyspnea measured by the Modified Medical Research Council (mMRC) Dyspnea Scale.Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
  • AddedPhysical activity level measured by the International Physical Activity Questionnaire - Short Form (IPAQ-SF), MET-minutes/week.Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
  • AddedIncidence of postoperative pulmonary complications defined by the European Perioperative Clinical Outcome (EPCO) criteria.Time frame: From hospital discharge to 12-week follow-up.
  • AddedHealth-related quality of life measured by the EQ-5D-5L descriptive system (index value).Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
  • AddedSelf-rated health measured by the EuroQol Visual Analogue Scale (EQ-VAS).Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
  • RemovedDyspneaTime frame: Baseline, 8 weeks, and 12 weeks
  • RemovedPhysical Activity LevelTime frame: Baseline, 8 weeks, and 12 weeks
  • RemovedPostoperative Pulmonary ComplicationsTime frame: Post-surgery to 12-week follow-up
  • RemovedHealth-Related Quality of LifeTime frame: Baseline, 8 weeks, and 12 weeks
Oct 21, 2026
Title
Impact of a Telerehabilitation-based Therapeutic Exercise Program onfor Postoperative Recovery in Patients With Lung Cancer: A Randomized Controlled Trial.
Oct 21, 2026
Registered
First appeared on the registry
Oct 6, 2026
Show all 2 updates
  1. Oct 21, 2026
    Not yet recruiting→Recruiting
    Hospital Universitario Virgen Macarena is now Recruiting
    Start date Oct 2026→Sep 8, 2026 (now actual)
    Eligibility 1 exclusion criterion edited
    What changed in the criteria
    Exclusion criteria
    • EditedHistory of another malignancy within the past five yearsone year.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Functional CapacityNow Functional capacity measured by the One-Minute Sit-to-Stand Test (1MSTS)Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up) → Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
    Secondary outcomes 5 added, 4 removed
    What changed in the outcomes
    • AddedDyspnea measured by the Modified Medical Research Council (mMRC) Dyspnea Scale.Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
    • AddedPhysical activity level measured by the International Physical Activity Questionnaire - Short Form (IPAQ-SF), MET-minutes/week.Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
    • AddedIncidence of postoperative pulmonary complications defined by the European Perioperative Clinical Outcome (EPCO) criteria.Time frame: From hospital discharge to 12-week follow-up.
    • AddedHealth-related quality of life measured by the EQ-5D-5L descriptive system (index value).Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
    • AddedSelf-rated health measured by the EuroQol Visual Analogue Scale (EQ-VAS).Time frame: Baseline (pre-surgery), 8 weeks (post-intervention), and 12 weeks (4-week follow-up).
    • RemovedDyspneaTime frame: Baseline, 8 weeks, and 12 weeks
    • RemovedPhysical Activity LevelTime frame: Baseline, 8 weeks, and 12 weeks
    • RemovedPostoperative Pulmonary ComplicationsTime frame: Post-surgery to 12-week follow-up
    • RemovedHealth-Related Quality of LifeTime frame: Baseline, 8 weeks, and 12 weeks
    Title Impact of a Telerehabilitation-based Therapeutic Exercise Program onfor Postoperative Recovery in Patients With Lung Cancer: A Randomized Controlled Trial.
    + 1 other change: verification date
  2. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07861282
Collaborators
Hospital Universitario Virgen Macarena
Responsible party
Maria Jesus Casuso-Holgado (Associate Professor, University of Seville) — Principal investigator
First posted
Oct 6, 2026
Start date
Sep 8, 2026
Primary completion
Apr 2028 (estimated)
Completion
Nov 2028 (estimated)
Last update
Oct 21, 2026

Study contacts

David Ortega Valle, PT, MSc
Contact
davortval@alum.us.es
663616650 ext. +34
María Jesús Casuso Holgado, PT, PhD
Contact
mcasuso@us.es
659213135 ext. +34
María Jesús Casuso Holgado
principal investigator · University of Seville

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion